Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation.
Autor: | Yamashita, Takaya, Fujishima, Naohito, Miura, Masatomo, Niioka, Takenori, Abumiya, Maiko, Shinohara, Yoshinori, Ubukawa, Kumi, Nara, Miho, Fujishima, Masumi, Kameoka, Yoshihiro, Tagawa, Hiroyuki, Hirokawa, Makoto, Takahashi, Naoto |
---|---|
Předmět: |
KIDNEY injuries
TACROLIMUS HEMATOPOIETIC stem cell transplantation GENETIC polymorphisms PHARMACOKINETICS THERAPEUTICS ACUTE kidney failure ALLELES ANTIFUNGAL agents COMPARATIVE studies CONTROLLED release preparations DRUG interactions DOSE-effect relationship in pharmacology HETEROCYCLIC compounds IMMUNOSUPPRESSIVE agents LONGITUDINAL method RESEARCH methodology MEDICAL cooperation OXIDOREDUCTASES RESEARCH EVALUATION research RANDOMIZED controlled trials GENOTYPES PHARMACODYNAMICS |
Zdroj: | Cancer Chemotherapy & Pharmacology; Jul2016, Vol. 78 Issue 1, p111-118, 8p |
Abstrakt: | |
Databáze: | Complementary Index |
Externí odkaz: |